Institutional investors face complex decisions—where to allocate capital, which managers to trust, how to weather volatility. These choices can’t rely on instinct alone. They require data, structure, ...
SWOG 0941: A phase II study of sorafenib and erlotinib in patients (pts) with advanced gallbladder cancer or cholangiocarcinoma. This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results